Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Feb 09, 2021 7:35pm
196 Views
Post# 32520464

RE:What is wrong with investors?

RE:What is wrong with investors?

gojotv! wrote: Theralase has verifiably CURED cancer in half the patients in this Phase2 study, even though the first treatments were botched AND there are still results pending from 2 more patients!
Why is no one buying?
Are people allergic to money?
Is it all the sciency stuff they don't understand?
Do they prefer giving their money to cancer charities instead?
WTF is wrong with people?!




Let them be allergic to money ; ).  Their loss continues to be our cumulative gains.  If able, just keep loading as we stand to gain A LOT.  As painful as it is to be on this often manipulated dumpster exchange, this opportunity comes around only once....

1).  An under 40 million MC company with a fast tracked Ph 2 & a compound/ACT that could realistically get Ph 2-based FDA approval late next year.

2).  A company that has patent protection for TLD-1433 & tens of thousands of more compounds until minimum June 2034 & proprietary protection of the synthesis of TLD-1433 until June 2054.

3).  A company that has the key to not only a novel method of treatment/management of cancer, but perhaps a cure....utilizing its unique mechanism of mass destruction & concomitant immunogenic cell death to keep the enemy away.  

4).  A company that can boast a preliminary testament to improvement in overall survival after only a single treatment (ph 1 patients 5 & 6 cancer-free at 18 months), which bodes well for future post-marketing confirmatory studies.

5).  A company that has done the above for pennies on the dollar...another unique feat in drug development.

& more...

This company is on the verge of being fully derisked...relative to other biotechs & risk-adjusted, our MC should be adjusted by an order of magnitude based on where we stand today.  The pps is no more than a bad joke...easy to ignore, but something to take full advantage of.  Best...CS.

<< Previous
Bullboard Posts
Next >>